PolyPid Ltd.
Support and Resistance Levels
Past performance
News About PYPD
All events for PYPD
All deals for PYPD
Financial Ratios
Financial Statements
PYPD vs Sector & Peers
About PolyPid Ltd.
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials. It is being evaluated for its efficacy in preventing surgical site infections (SSIs) following both sternal (bone) and abdominal (soft tissue) procedures. Established in 2008, PolyPid Ltd. is headquartered in Petah Tikva, Israel. Website polypid.com
Headquarters Petah Tikva, HM, IL